Stock 6491 PEGAVISION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pegavision Corporation

Equities

6491

TW0006491004

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
524 TWD +1.35% Intraday chart for Pegavision Corporation +14.41% +32.16%
Apr. 30 Pegavision Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jan. 29 Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 12,705 19,810 29,890 29,680 30,927 41,496 - -
Enterprise Value (EV) 1 12,193 19,038 28,561 27,817 25,966 34,993 32,982 30,235
P/E ratio 24 x 27.9 x 24.1 x 19.4 x 17.5 x 19.3 x 16.9 x 13.8 x
Yield 1.38% 1.77% 1.99% 2.36% 2.52% 2.18% 2.54% 2.91%
Capitalization / Revenue 3.79 x 4.98 x 5.34 x 4.7 x 4.55 x 5.56 x 4.72 x 4.26 x
EV / Revenue 3.63 x 4.79 x 5.1 x 4.4 x 3.82 x 4.69 x 3.75 x 3.1 x
EV / EBITDA 9.53 x 13 x 13.5 x 10.1 x 8.9 x 10.4 x 8.34 x 6.93 x
EV / FCF -24.7 x 39.3 x 36 x 43.7 x -83.2 x 14.7 x 12 x 9.33 x
FCF Yield -4.05% 2.55% 2.77% 2.29% -1.2% 6.82% 8.34% 10.7%
Price to Book 2.8 x 4.31 x 5.45 x 4.62 x 3.12 x 3.46 x 2.65 x 2.23 x
Nbr of stocks (in thousands) 70,000 70,000 70,000 70,000 78,000 78,000 - -
Reference price 2 181.5 283.0 427.0 424.0 396.5 532.0 532.0 532.0
Announcement Date 2/10/20 1/29/21 2/15/22 2/14/23 1/29/24 - - -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,355 3,978 5,595 6,321 6,790 7,460 8,787 9,739
EBITDA 1 1,279 1,465 2,117 2,753 2,918 3,362 3,954 4,360
EBIT 1 592.1 855.7 1,460 1,820 1,981 2,414 2,845 3,188
Operating Margin 17.65% 21.51% 26.09% 28.79% 29.18% 32.36% 32.38% 32.73%
Earnings before Tax (EBT) 1 560.9 844.9 1,444 1,817 1,979 2,554 3,018 3,543
Net income 1 475.5 715.4 1,249 1,542 1,656 2,154 2,556 3,005
Net margin 14.17% 17.98% 22.32% 24.4% 24.39% 28.87% 29.09% 30.86%
EPS 2 7.560 10.16 17.72 21.84 22.61 27.61 31.45 38.53
Free Cash Flow 1 -494 484.6 792.4 636.6 -312 2,387 2,752 3,240
FCF margin -14.72% 12.18% 14.16% 10.07% -4.6% 32% 31.32% 33.27%
FCF Conversion (EBITDA) - 33.08% 37.44% 23.13% - 71% 69.61% 74.31%
FCF Conversion (Net income) - 67.74% 63.46% 41.28% - 110.82% 107.67% 107.82%
Dividend per Share 2 2.500 5.000 8.500 10.00 10.00 11.62 13.51 15.50
Announcement Date 2/10/20 1/29/21 2/15/22 2/14/23 1/29/24 - - -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,554 1,488 1,415 1,642 1,776 1,460 1,615 1,677 2,038 1,725 1,750 2,010 1,975 1,782 1,983
EBITDA 1 - - - - - - - - - 794.8 587.8 638.8 773.2 - -
EBIT 1 433.4 417.9 407.9 467.5 526.6 414.2 436.4 432.1 698.4 591.7 552.8 628 692 541 644
Operating Margin 27.88% 28.07% 28.83% 28.48% 29.64% 28.38% 27.02% 25.76% 34.27% 34.3% 31.59% 31.24% 35.04% 30.36% 32.48%
Earnings before Tax (EBT) 1 431.5 422.7 405.7 487.5 501.4 403.3 438.9 457.5 678.9 590.7 619 - - 457 -
Net income 1 367.3 360 342 421.4 418.8 338.4 365.9 378 573.6 509.8 520 - - 392 -
Net margin 23.63% 24.18% 24.17% 25.67% 23.58% 23.18% 22.65% 22.54% 28.15% 29.55% 29.71% - - 22% -
EPS 2 5.180 5.120 4.870 5.980 5.910 4.830 5.230 5.210 7.340 6.510 6.120 6.707 7.740 5.020 -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/15/22 4/25/22 7/25/22 10/31/22 2/14/23 5/1/23 7/31/23 10/31/23 1/29/24 4/30/24 - - - - -
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 512 772 1,329 1,863 4,961 6,503 8,514 11,261
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -494 485 792 637 -312 2,387 2,752 3,240
ROE (net income / shareholders' equity) 15.7% 16.5% 24.8% 25.9% 20.3% 20.4% 18.5% 16.7%
ROA (Net income/ Total Assets) 10.1% 12.2% 16.7% 17% 14.1% 14.8% 16% 17.1%
Assets 1 4,729 5,863 7,490 9,063 11,710 14,554 15,975 17,573
Book Value Per Share 2 64.90 65.70 78.40 91.80 127.0 154.0 200.0 238.0
Cash Flow per Share - - - - - - - -
Capex 1 1,266 710 1,841 1,411 1,112 651 700 700
Capex / Sales 37.75% 17.84% 32.9% 22.32% 16.37% 8.73% 7.97% 7.19%
Announcement Date 2/10/20 1/29/21 2/15/22 2/14/23 1/29/24 - - -
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Pegavision Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
532 TWD
Average target price
518.2 TWD
Spread / Average Target
-2.60%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
PEGAVISION CORPORATION Stock Pegavision Corporation
+32.16% 1.28B
ESSILORLUXOTTICA Stock EssilorLuxottica
+10.74% 97.27B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-5.14% 17.84B
AUTEK CHINA INC. Stock Autek China Inc.
-16.61% 2.33B
WARBY PARKER INC. Stock Warby Parker Inc.
-12.77% 1.46B
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-34.97% 755M
MENICON CO., LTD. Stock Menicon Co., Ltd.
-36.42% 740M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-7.58% 669M
VIZIONFOCUS INC. Stock Vizionfocus Inc.
+25.66% 515M
VISCO VISION INC. Stock Visco Vision Inc.
+16.82% 488M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. 6491 Stock
  4. Financials Pegavision Corporation